SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

Share Price is delayed by 15 minutes
Get Live Data
93.50    3.00 (3.31%)
Bid:
92.00
Ask:
95.00
Spread: 3.00 (3.261%)
Market Cap: £104.94m
BBSN Live PriceLast checked at - London Stock Exchange

Intraday Brave Bison Share Chart

Mark Ritson Option Exercise

Today 07:00

RNS Number : 1823I
Brave Bison Group PLC
15 June 2026
 

15 June 2026

 

Brave Bison Group plc

 

("Brave Bison" or the "Company", together with its subsidiaries "the Group") 

 

Mark Ritson Option Exercise

 

Mark Ritson invests a further £2 million in Brave Bison,

increasing stake to 7%

 

Proceeds to strengthen Group balance sheet

and net cash position

 

Brave Bison, the next-generation marketing and technology partner for global brands, announces that Moonlight Graham Pty Limited , a company beneficially owned by Professor Mark Ritson, has exercised in full its existing option (the "Option") to acquire 4,081,632 new Ordinary Shares in the Company ("Ordinary Shares") for a total consideration of £2 million (the "Option Exercise"). The exercise price for the Option Exercise is 49 pence per Ordinary Share.

 

Professor Mark Ritson is Founder of MiniMBA, the category-leading training and eLearning business for marketing professionals acquired by Brave Bison in 2025. The terms of Option, which was put in place to enable meaningful ongoing management equity participation, were announced by the Company on 25 June 2025.

 

MiniMBA has performed strongly since acquisition by Brave Bison, with the division reporting 18% organic revenue growth from the first cohort of learners in 2026, and recently announced two of its largest-ever contract wins.

 

Following the Option Exercise, no further Ordinary Shares are capable of exercise under the Option and the new Ordinary Shares issued are locked in until 15 July 2027.

 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on 18 June 2026 and the new Ordinary Shares will, on issue, rank pari passu in all respects with the Company's existing Ordinary Shares.

 

On Admission, Mark Ritson will be beneficially interested in 8,163,264 Ordinary Shares, representing 7.0% of the Company's enlarged issued share capital.

 

Mark Ritson, Founder of MiniMBA, commented:

 

"I'm delighted to be increasing my investment in Brave Bison. Having seen the business up close since the acquisition last year, I'm more convinced than ever that it's built on the right things - discipline, genuine commercial substance, and people who know what they're doing. I'm fully committed to the future here, and I'm backing that belief with my own money."

 

Total Voting Rights

 

On Admission, the Company will have a total of 116,319,751 Ordinary Shares in issue. No Ordinary Shares are held in treasury. The figure of 116,319,751 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For further information please contact:  

 

Brave Bison Group plc via Cavendish 

Oliver Green, Executive Chairman  

Theo Green, Chief Growth Officer  

Philippa Norridge, Chief Financial Officer  

 

Cavendish Capital Markets Tel: +44 (0) 20 7220 0500 

Nominated Adviser & Joint Broker  

Ben Jeynes / Teddy Whiley - Corporate Finance 

Michael Johnson / Sunila de Silva - ECM

 

Singer Capital Markets Tel: +44 (0) 20 7496 3000

Joint Broker 

Paul Richards

Alex Bond

 

About Brave Bison

 

Brave Bison is a next-generation marketing and technology partner to global brands. We sell services, training and media to the largest advertisers in the world. Operating across eight countries, our team of approximately 350 people is based in key hubs in the UK, US, India, Egypt and Australia, with additional remote talent across Europe.

 

Brave Bison operates through three divisions. Our Consultancy & Marketing Services division deploys insight-led and AI-enabled growth strategies using social and digital media, working on behalf of global brands including New Balance, Primark and Google. Our Sport & Entertainment division works with global rights holders and entertainment companies such as PGA Tour, US Open, Real Madrid and Guiness World Records to monetise content on YouTube and grow fan engagement online. Our Marketing Skills & Capabilities division comprises MiniMBA, an eLearning platform that provides MBA-level marketing education for enterprise brands such as Nestle, Carlsberg and Salesforce

 

Brave Bison is the largest shareholder in System1 Group plc, a UK-based marketing research platform that helps brands improve the effectiveness of their advertising using behavioural science and proprietary testing tools. Its platform combines consumer insight with data analytics to guide creative development, media planning, and brand strategy for global advertisers including TikTok, Pfizer and Ikea. System1 is listed on the AIM market of the London Stock Exchange and Brave Bison owns a 28% shareholding

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBUGDLRXBDGLD
Date   Source Headline
29th May 202410:05 amRNSForm 8.5 (EPT/NON-RI)
28th May 20249:11 amRNSForm 8.5 (EPT/NON-RI)
28th May 20247:00 amRNSForm 8 (OPD) The Mission Group plc
28th May 20247:00 amRNSForm 8 (OPD) Brave Bison Group plc
24th May 20244:04 pmRNSForm 8.3 - Brave Bison Group
24th May 20247:00 amRNSNotice of AGM
23rd May 20247:11 amRNSForm 8.5 (EPT/NON-RI)
22nd May 20245:21 pmRNSForm 8.3 - Brave Bison Group PLC
22nd May 20247:00 amRNSForm 8.5 (EPT/NON-RI)
21st May 20241:47 pmRNSForm 8.3 - Brave Bison Group PLC
21st May 202410:33 amRNSForm 8.5 (EPT/NON-RI)
20th May 202411:21 amRNSForm 8.5 (EPT/NON-RI)
17th May 20245:55 pmRNSForm 8.3 - Brave Bison Group PLC
17th May 20245:50 pmRNSForm 8.3 - Brave Bison Group PLC
17th May 20245:45 pmRNSForm 8.3 - Brave Bison Group PLC
17th May 20248:13 amRNSForm 8.5 (EPT/NON-RI)
16th May 202412:00 pmRNSForm 8.3 - Brave Bison Group PLC
16th May 202411:55 amRNSForm 8.3 - Brave Bison Group PLC
16th May 202411:39 amRNSForm 8.5 (EPT/NON-RI)
15th May 20248:17 amRNSHolding(s) in Company
15th May 20247:00 amRNSResponse re possible offer for The MISSION Group
15th May 20247:00 amRNSForm 8.5 (EPT/NON-RI)
14th May 20243:56 pmRNSForm 8.3 - Brave Bison Group PLC
14th May 20243:33 pmRNSHolding(s) in Company
14th May 20249:31 amRNSForm 8.5 (EPT/NON-RI)
13th May 202412:38 pmRNSForm 8.3 - Brave Bison Group PLC
13th May 20247:00 amRNSResponse to Press Speculation & Possible Offer
13th May 20247:00 amRNSPossible All Share Offer for The Mission Group plc
22nd Apr 20247:00 amRNSFinal Results
10th Apr 20247:00 amRNSNotice of Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSTrading Update
14th Dec 20234:15 pmRNSChange of Registered Office
12th Dec 20232:30 pmRNSGrant of RSU's and Director/PDMR Shareholding
23rd Nov 202311:00 amRNSDirector/PDMR Shareholding
20th Nov 20235:00 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSContract Wins & Investor Presentation
24th Oct 20235:15 pmRNSChange of Nominated Adviser and Broker
24th Oct 202312:30 pmRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSHalf-year Report
4th Sep 20237:00 amRNSNotice of Results & Investor Presentation
29th Aug 202312:16 pmRNSHolding(s) in Company
15th Aug 202310:00 amRNSHolding(s) in Company
22nd Jun 20234:40 pmRNSHolding(s) in Company
14th Jun 20233:01 pmRNSResult of AGM
14th Jun 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSNotice of AGM
10th May 20238:18 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.